Factors Affecting the Results of Treatment of Patients With Colorectal Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImmanuel Kant Baltic Federal University

About this trial

The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.

Eligibility criteria

Qualifiers

Histologically proven primary adenocarcinoma of bowel;

All patients who have indications for surgical treatment of colorectal cancer based on the decision of the oncological council;

Signed informed consent with agreement to attend all study visits;

Disqualifiers

Unresectable tumor or contradictions to surgery;

Indications for chemotherapy or radiation therapy prior to surgery;

Patient withdrawal from the trial or loss of follow-up;

Emergent operation;

Trial design

Treatments tested in this trial

  • Right hemicolectomy
  • Left hemicolectomy
  • Sigmoid colon resection
  • Anterior resection of the rectum
  • Low anterior resection of the rectum
  • Abdominoperineal resection
  • Total Colectomy

Treatment groups

1,200 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Immanuel Kant Baltic Federal University

Lead sponsor

Center of Endourology "Endocenter"

Collaborator